Age and Computed Tomography and Invasive Coronary Angiography in Stable Chest Pain: A Prespecified Secondary Analysis of the DISCHARGE Randomized Clinical Trial
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu randomizované kontrolované studie, časopisecké články
PubMed
38416472
PubMed Central
PMC10902776
DOI
10.1001/jamacardio.2024.0001
PII: 2815696
Knihovny.cz E-zdroje
- MeSH
- bolesti na hrudi etiologie diagnóza MeSH
- koronární angiografie metody MeSH
- lidé středního věku MeSH
- lidé MeSH
- nemoci koronárních tepen * komplikace diagnostické zobrazování MeSH
- počítačová rentgenová tomografie MeSH
- senioři MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- randomizované kontrolované studie MeSH
IMPORTANCE: The effectiveness and safety of computed tomography (CT) and invasive coronary angiography (ICA) in different age groups is unknown. OBJECTIVE: To determine the association of age with outcomes of CT and ICA in patients with stable chest pain. DESIGN, SETTING, AND PARTICIPANTS: The assessor-blinded Diagnostic Imaging Strategies for Patients With Stable Chest Pain and Intermediate Risk of Coronary Artery Disease (DISCHARGE) randomized clinical trial was conducted between October 2015 and April 2019 in 26 European centers. Patients referred for ICA with stable chest pain and an intermediate probability of obstructive coronary artery disease were analyzed in an intention-to-treat analysis. Data were analyzed from July 2022 to January 2023. INTERVENTIONS: Patients were randomly assigned to a CT-first strategy or a direct-to-ICA strategy. MAIN OUTCOMES AND MEASURES: MACE (ie, cardiovascular death, nonfatal myocardial infarction, or stroke) and major procedure-related complications. The primary prespecified outcome of this secondary analysis of age was major adverse cardiovascular events (MACE) at a median follow-up of 3.5 years. RESULTS: Among 3561 patients (mean [SD] age, 60.1 [10.1] years; 2002 female [56.2%]), 2360 (66.3%) were younger than 65 years, 982 (27.6%) were between ages 65 to 75 years, and 219 (6.1%) were older than 75 years. The primary outcome was MACE at a median (IQR) follow-up of 3.5 (2.9-4.2) years for 3523 patients (99%). Modeling age as a continuous variable, age, and randomization group were not associated with MACE (hazard ratio, 1.02; 95% CI, 0.98-1.07; P for interaction = .31). Age and randomization group were associated with major procedure-related complications (odds ratio, 1.15; 95% CI, 1.05-1.27; P for interaction = .005), which were lower in younger patients. CONCLUSIONS AND RELEVANCE: Age did not modify the effect of randomization group on the primary outcome of MACE but did modify the effect on major procedure-related complications. Results suggest that CT was associated with a lower risk of major procedure-related complications in younger patients. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02400229.
Administrative Centre Health Care District of Southwestern Finland Turku Finland
Bavarian Cancer Registry Bavarian Health and Food Safety Authority Munich Germany
Berlin Institute of Health at Charité Universitätsmedizin Berlin Berlin Germany
Centro de Investigacion Biomedica en Red Madrid Spain
County Clinical Emergency Hospital Targu Mures Targu Mures Romania
Department of Biomedical Sciences Humanitas University Milan Italy
Department of Cardiology Aintree University Hospital Liverpool United Kingdom
Department of Cardiology Alb Fils Kliniken Göppingen Germany
Department of Cardiology Basurto Hospital Bilbao Spain
Department of Cardiology Centro Hospitalar de Vila Nova de Gaia Espinho Vila Nova de Gaia Portugal
Department of Cardiology Copenhagen University Hospital Amager and Hvidovre Hvidovre Denmark
Department of Cardiology Herlev Gentofte Hospital Hellerup Denmark
Department of Cardiology Hospital of Lithuanian University of Health Sciences Kaunas Lithuania
Department of Cardiology Institute for Cardiovascular Diseases of Vojvodina Novi Sad Serbia
Department of Cardiology Internal Medicine Clinic Clinical Hospital Center Zemun Belgrade Serbia
Department of Cardiology Liverpool University Hospital NHS Foundation Trust Liverpool United Kingdom
Department of Cardiology Medical Academy Lithuanian University of Health Sciences Kaunas Lithuania
Department of Cardiology Motol University Hospital Prague Czech Republic
Department of Cardiology Nordsjaellands Hospital University of Copenhagen Hilleroed Denmark
Department of Cardiology Paul Stradins Clinical University Hospital Riga Latvia
Department of Cardiology Provincial Specialist Hospital in Wrocław Wrocław Poland
Department of Cardiology Southeastern Health and Social Care Trust Belfast United Kingdom
Department of Cardiology St Vincent's University Hospital and School of Medicine Dublin Ireland
Department of Cardiology University of Leipzig Heart Centre Leipzig Germany
Department of Clinical Medicine University of Copenhagen Copenhagen Denmark
Department of Imaging Methods Motol University Hospital Prague Czech Republic
Department of Radiology Aintree University Hospital Liverpool United Kingdom
Department of Radiology Basurto Hospital Bilbao Spain
Department of Radiology Innsbruck Medical University Innsbruck Austria
Department of Radiology Medical Imaging Center Semmelweis University Budapest Hungary
Department of Radiology Paul Stradins Clinical University Hospital Riga Latvia
Department of Radiology Provincial Specialist Hospital in Wrocław Wrocław Poland
Department of Radiology St Vincent's University Hospital Dublin Ireland
Department of Radiology University of Cagliari Cagliari Italy
Department of Radiology University of Leipzig Heart Centre Leipzig Germany
Deutsches Herzzentrum der Charité Berlin Germany
DZHK partner site Berlin Germany
Edge Hill University Ormskirk United Kingdom
Faculty of Health and Life Sciences University of Liverpool Liverpool United Kingdom
Faculty of Medicine University of Belgrade Belgrade Serbia
Faculty of Medicine University of Novi Sad Novi Sad Serbia
Geisel School of Medicine at Dartmouth Hanover New Hampshire
Golden Jubilee National Hospital Clydebank United Kingdom
Heart and Vascular Center Semmelweis University Budapest Hungary
Heart Center Turku University Hospital and University of Turku Turku Finland
National Institute of Cardiology Warsaw Poland
School of Cardiovascular and Metabolic Health University of Glasgow Glasgow United Kingdom
School of Medicine University College Dublin Dublin Ireland
Service of Cardiology and Internal Medicine Mater Olbia Hospital Olbia Italy
Turku PET Centre Turku University Hospital and University of Turku Turku Finland
Zobrazit více v PubMed
Haase R, Schlattmann P, Gueret P, et al. ; COME-CCT Consortium . Diagnosis of obstructive coronary artery disease using computed tomography angiography in patients with stable chest pain depending on clinical probability and in clinically important subgroups: meta-analysis of individual patient data. BMJ. 2019;365:l1945. doi:10.1136/bmj.l1945 PubMed DOI PMC
Knuuti J, Wijns W, Saraste A, et al. ; ESC Scientific Document Group . 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407-477. doi:10.1093/eurheartj/ehz425 PubMed DOI
Dewey M, Rief M, Martus P, et al. . Evaluation of computed tomography in patients with atypical angina or chest pain clinically referred for invasive coronary angiography: randomised controlled trial. BMJ. 2016;355:i5441. doi:10.1136/bmj.i5441 PubMed DOI PMC
Chang HJ, Lin FY, Gebow D, et al. . Selective referral using CCTA vs direct referral for individuals referred to invasive coronary angiography for suspected CAD: a randomized, controlled, open-label trial. JACC Cardiovasc Imaging. 2019;12(7 Pt 2):1303-1312. doi:10.1016/j.jcmg.2018.09.018 PubMed DOI
Hoffmann U, Douglas PS. The PROMISE trial: an inside perspective. J Cardiovasc Comput Tomogr. 2015;9(4):252-254. doi:10.1016/j.jcct.2015.05.002 PubMed DOI
Maurovich-Horvat P, Bosserdt M, Kofoed KF, et al. ; DISCHARGE Trial Group . CT or invasive coronary angiography in stable chest pain. N Engl J Med. 2022;386(17):1591-1602. doi:10.1056/NEJMoa2200963 PubMed DOI
Newby DE, Adamson PD, Berry C, et al. ; SCOT-HEART Investigators . Coronary CT angiography and 5-year risk of myocardial infarction. N Engl J Med. 2018;379(10):924-933. doi:10.1056/NEJMoa1805971 PubMed DOI
Foy AJ, Dhruva SS, Peterson B, Mandrola JM, Morgan DJ, Redberg RF. Coronary computed tomography angiography vs functional stress testing for patients with suspected coronary artery disease: a systematic review and meta-analysis. JAMA Intern Med. 2017;177(11):1623-1631. doi:10.1001/jamainternmed.2017.4772 PubMed DOI PMC
Gulati M, Levy PD, Mukherjee D, et al. . 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;144(22):e368-e454. doi:10.1161/CIR.0000000000001030 PubMed DOI
Tsao CW, Aday AW, Almarzooq ZI, et al. . Heart disease and stroke statistics—2022 Update: a report from the American Heart Association. Circulation. 2022;145(8):e153-e639. doi:10.1161/CIR.0000000000001052 PubMed DOI
van Rosendael AR, van den Hoogen IJ, Lin FY, et al. . Age-related compositional plaque burden by CT in patients with future ACS. J Cardiovasc Comput Tomogr. 2022;16(6):491-497. doi:10.1016/j.jcct.2022.05.005 PubMed DOI
Mortensen MB, Gaur S, Frimmer A, et al. . Association of age with the diagnostic value of coronary artery calcium score for ruling out coronary stenosis in symptomatic patients. JAMA Cardiol. 2022;7(1):36-44. doi:10.1001/jamacardio.2021.4406 PubMed DOI PMC
Feuchtner GM, Beyer C, Langer C, et al. . The atherosclerotic profile of a young symptomatic population between 19 and 49 years: coronary computed tomography angiography or coronary artery calcium score? J Cardiovasc Dev Dis. 2021;8(11):157. doi:10.3390/jcdd8110157 PubMed DOI PMC
Kim M, Lee SP, Kwak S, et al. . Impact of age on coronary artery plaque progression and clinical outcome: a PARADIGM substudy. J Cardiovasc Comput Tomogr. 2021;15(3):232-239. doi:10.1016/j.jcct.2020.09.009 PubMed DOI
Napp AE, Haase R, Laule M, et al. ; DISCHARGE Trial Group . Computed tomography vs invasive coronary angiography: design and methods of the pragmatic randomised multicentre DISCHARGE trial. Eur Radiol. 2017;27(7):2957-2968. doi:10.1007/s00330-016-4620-z PubMed DOI
Dodd JD, Kofoed KF, Dewey M; DISCHARGE Trial Group . CT or Invasive Coronary Angiography in Stable Chest Pain. Reply. N Engl J Med. 2022;387(4):379-380. doi:10.1056/NEJMc2206973 PubMed DOI
Scanlon PJ, Faxon DP, Audet AM, et al. . ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol. 1999;33(6):1756-1824. doi:10.1016/S0735-1097(99)00126-6 PubMed DOI
Perk J, De Backer G, Gohlke H, et al. ; European Association for Cardiovascular Prevention & Rehabilitation (EACPR); ESC Committee for Practice Guidelines (CPG) . European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on cardiovascular disease prevention in clinical practice (constituted by representatives of 9 societies and by invited experts). Eur Heart J. 2012;33(13):1635-1701. doi:10.1093/eurheartj/ehs092 PubMed DOI
Montalescot G, Sechtem U, Achenbach S, et al. ; Task Force Members; ESC Committee for Practice Guidelines; Document Reviewers . 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949-3003. doi:10.1093/eurheartj/eht296 PubMed DOI
Windecker S, Kolh P, Alfonso F, et al. ; Authors/Task Force members . 2014 ESC/EACTS Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541-2619. doi:10.1093/eurheartj/ehu278 PubMed DOI
Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496-509. doi:10.1080/01621459.1999.10474144 DOI
Nozue T, Yamamoto S, Tohyama S, et al. . Impacts of age on coronary atherosclerosis and vascular response to statin therapy. Heart Vessels. 2014;29(4):456-463. doi:10.1007/s00380-013-0387-1 PubMed DOI
Lowenstern A, Alexander KP, Hill CL, et al. . Age-related differences in the noninvasive evaluation for possible coronary artery disease: insights from the prospective multicenter imaging study for evaluation of chest pain (PROMISE) trial. JAMA Cardiol. 2020;5(2):193-201. doi:10.1001/jamacardio.2019.4973 PubMed DOI PMC
Adamson PD, Williams MC, Dweck MR, et al. ; SCOT-HEART Investigators . Guiding therapy by coronary CT angiography improves outcomes in patients with stable chest pain. J Am Coll Cardiol. 2019;74(16):2058-2070. doi:10.1016/j.jacc.2019.07.085 PubMed DOI PMC
Hoffmann U, Ferencik M, Udelson JE, et al. ; PROMISE Investigators . Prognostic value of noninvasive cardiovascular testing in patients with stable chest pain: insights from the PROMISE trial (prospective multicenter imaging study for evaluation of chest pain). Circulation. 2017;135(24):2320-2332. doi:10.1161/CIRCULATIONAHA.116.024360 PubMed DOI PMC
Zhang S, Liang F, Li W, Hu X. Subgroup analyses in reporting of phase III clinical trials in solid tumors. J Clin Oncol. 2015;33(15):1697-1702. doi:10.1200/JCO.2014.59.8862 PubMed DOI
Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. Statistics in medicine–reporting of subgroup analyses in clinical trials. N Engl J Med. 2007;357(21):2189-2194. doi:10.1056/NEJMsr077003 PubMed DOI
Wang X, Piantadosi S, Le-Rademacher J, Mandrekar SJ. Statistical considerations for subgroup analyses. J Thorac Oncol. 2021;16(3):375-380. doi:10.1016/j.jtho.2020.12.008 PubMed DOI PMC
Lagakos SW. The challenge of subgroup analyses—reporting without distorting. N Engl J Med. 2006;354(16):1667-1669. doi:10.1056/NEJMp068070 PubMed DOI
Sormani MP, Bruzzi P. Reporting of subgroup analyses from clinical trials. Lancet Neurol. 2012;11(9):747. doi:10.1016/S1474-4422(12)70181-3 PubMed DOI
VanderWeele TJ, Knol MJ. Interpretation of subgroup analyses in randomized trials: heterogeneity vs secondary interventions. Ann Intern Med. 2011;154(10):680-683. doi:10.7326/0003-4819-154-10-201105170-00008 PubMed DOI PMC
Madhavan MV, Gersh BJ, Alexander KP, Granger CB, Stone GW. Coronary artery disease in patients ≥80 years of age. J Am Coll Cardiol. 2018;71(18):2015-2040. doi:10.1016/j.jacc.2017.12.068 PubMed DOI
Marcantonio ER, Aneja J, Jones RN, et al. . Maximizing clinical research participation in vulnerable older persons: identification of barriers and motivators. J Am Geriatr Soc. 2008;56(8):1522-1527. doi:10.1111/j.1532-5415.2008.01829.x PubMed DOI PMC
Douglas PS, Nanna MG, Kelsey MD, et al. ; PRECISE Investigators . Comparison of an initial risk–based testing strategy vs usual testing in stable symptomatic patients with suspected coronary artery disease: the PRECISE randomized clinical trial. JAMA Cardiol. 2023;8(10):904-914. doi:10.1001/jamacardio.2023.2595 PubMed DOI PMC
ClinicalTrials.gov
NCT02400229